ソフトミスト吸入器の世界市場レポート 2025年

ソフトミスト吸入器市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.3％で42億4,000万米ドルに成長します。予測期間中の成長は、世界の汚染レベルの上昇、高齢者人口の増加、喘息やCOPDの罹患率の増加、非侵襲的ドラッグデリバリー方法の採用の増加、新興市場におけるヘルスケアインフラの拡大などに起因しています。予測期間における主な動向には、携帯可能で使いやすい吸入器への需要の高まり、環境に優しく持続可能な吸入器設計への注目、吸入器とデジタルヘルスソリューションの統合の増加、個別化された患者中心の治療へのシフト、ドラッグデリバリー技術の進歩などがあります。

喘息の有病率の増加は、今後数年間のソフトミスト吸入器市場の拡大を促進すると予想されます。喘息は、気道の炎症と狭窄を引き起こし、呼吸を困難にする慢性呼吸器疾患です。喘息患者の増加は、主に大気汚染への暴露の増加に起因しており、呼吸器系の状態を悪化させ、時間とともに肺機能にダメージを与えます。ソフトミスト吸入器は、喘息やその他の慢性閉塞性肺疾患の管理において、細かくゆっくりと動くミスト状の薬剤を肺に直接送り込むことで、薬剤の沈着を改善し、最小限の労力で呼吸器系を緩和します。例えば、2023年12月、オーストラリア統計局は、2022年にはオーストラリアで約280万人（人口の10.8％）が喘息を患っていると報告しました。さらに、喘息患者の3人に1人（33.9％）が喘息薬を毎日使用していると報告しました。その結果、喘息と慢性閉塞性肺疾患（COPD）の有病率の上昇がソフトミスト吸入器市場の成長に寄与しています。

ソフトミスト吸入器（SMI）市場の主要企業は、市場での存在感を高め、製品へのアクセス性を向上させるため、戦略的パートナーシップに注力しています。これらの企業は、研究機関、テクノロジー企業、地域のヘルスケアプロバイダーと協力することで、それぞれの強みを組み合わせ、革新的で患者中心の吸入療法を提供する上で競合優位に立つことを目指しています。例えば、2024年、ジェネリックおよびカスタマイズされた吸入器デバイスの設計と供給を専門とする英国の企業Merxin Ltd.は、ドイツの医療機器メーカーOECHSLERhealthとパートナーシップを結びました。この提携は、ソフトミスト吸入器（SMI）Powerhouseの立ち上げにつながりました。この構想は、医薬品開発者の市場参入を加速させることを目的としており、OECHSLER Health社との提携により、同社の製造・組立の専門知識とメルシン独自のSMI設計を融合させることも含まれています。両社は共に、知的財産権の保護、性能、信頼性、スピード、費用対効果において、新たな業界標準を打ち立てる計画です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ソフトミスト吸入器PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のソフトミスト吸入器市場：成長率分析
• 世界のソフトミスト吸入器市場の実績：規模と成長, 2019-2024
• 世界のソフトミスト吸入器市場の予測：規模と成長, 2024-2029, 2034F
• 世界ソフトミスト吸入器総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のソフトミスト吸入器市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポータブルソフトミスト吸入器
• 据置型ソフトミスト吸入器
• 世界のソフトミスト吸入器市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 喘息
• 慢性閉塞性肺疾患（COPD）
• 呼吸器疾患
• その他の用途
• 世界のソフトミスト吸入器市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 在宅ケア設定
• その他のエンドユーザー
• 世界のソフトミスト吸入器市場ポータブルソフトミスト吸入器のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ハンドヘルド再利用可能ソフトミスト吸入器
• 使い捨てシングルユースソフトミスト吸入器
• コンパクトな旅行用吸入器
• 小児用ポータブルソフトミスト吸入器
• 世界のソフトミスト吸入器市場据置型ソフトミスト吸入器の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 在宅ケア用据置型吸入器
• 病院グレードのソフトミスト吸入器
• 統合ネブライザーシステム
• 長期治療装置

第7章 地域別・国別分析

• 世界のソフトミスト吸入器市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のソフトミスト吸入器市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ソフトミスト吸入器市場：競合情勢
• ソフトミスト吸入器市場：企業プロファイル
  • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim Pharma GmbH & Co. KG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Philips Respironics Inc.
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• 3M Healthcare
• Omron Healthcare Inc.
• AptarGroup Inc.
• Chiesi Farmaceutici S.p.A.
• Cipla Limited
• Hikma Pharmaceuticals plc
• Mundipharma International Limited
• Hovione Ltd.
• Vectura Group Limited
• MannKind Corporation
• H&T Presspart Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ソフトミスト吸入器市場2029：新たな機会を提供する国
• ソフトミスト吸入器市場2029：新たな機会を提供するセグメント
• ソフトミスト吸入器市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A soft mist inhaler (SMI) is an inhalation device that delivers medication as a slow-moving, long-lasting aerosol mist, generated without the use of propellants. This method allows for better lung deposition and easier inhalation, making it especially beneficial for patients with limited inspiratory capacity.

The main product types of soft mist inhalers include portable soft mist inhalers and stationary soft mist inhalers. Portable soft mist inhalers are designed for delivering medication in the form of a fine mist for treating respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). The various applications of soft mist inhalers include asthma, COPD, and other respiratory diseases. They are used by several end-users, including hospitals and clinics, home care settings, and others.

The soft mist inhalers market research report is one of a series of new reports from The Business Research Company that provides soft mist inhalers market statistics, including the soft mist inhalers industry global market size, regional shares, competitors with the soft mist inhalers market share, detailed soft mist inhalers market segments, market trends, and opportunities, and any further data you may need to thrive in the soft mist inhalers industry. This soft mist inhalers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The soft mist inhalers market size has grown strongly in recent years. It will grow from $2.84 billion in 2024 to $3.09 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the increasing prevalence of respiratory diseases, the growing adoption of inhaler devices for asthma and COPD treatment, rising healthcare awareness, growing demand for advanced healthcare solutions, and increasing healthcare expenditure and access.

The soft mist inhalers market size is expected to see strong growth in the next few years. It will grow to $4.24 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth during the forecast period can be attributed to rising global pollution levels, a growing geriatric population, an increasing incidence of asthma and COPD, the rising adoption of non-invasive drug delivery methods, and expanding healthcare infrastructure in emerging markets. Key trends in the forecast period include growing demand for portable and easy-to-use inhalers, a focus on eco-friendly and sustainable inhaler designs, increasing integration of digital health solutions with inhalers, a shift toward personalized and patient-centric treatments, and advancements in drug delivery technology.

The growing prevalence of asthma is expected to drive the expansion of the soft mist inhalers market in the coming years. Asthma is a chronic respiratory disease that leads to inflammation and narrowing of the airways, making breathing difficult. The rise in asthma cases is mainly attributed to the increasing exposure to air pollution, which worsens respiratory conditions and damages lung function over time. Soft mist inhalers assist in managing asthma and other chronic obstructive pulmonary diseases by delivering a fine, slow-moving mist of medication directly to the lungs, improving drug deposition and providing respiratory relief with minimal effort in coordination. For example, in December 2023, the Australian Bureau of Statistics reported that in 2022, about 2.8 million people in Australia (10.8% of the population) had asthma. Additionally, one in three individuals with asthma (33.9%) reported using asthma medication daily. Consequently, the rising prevalence of asthma and chronic obstructive pulmonary disease (COPD) is contributing to the growth of the soft mist inhalers market.

Key players in the soft mist inhalers (SMIs) market are focusing on strategic partnerships to increase their market presence and improve product accessibility. These companies aim to combine their strengths to gain a competitive advantage in delivering innovative, patient-focused inhalation therapies by collaborating with research organizations, technology firms, and local healthcare providers. For instance, in 2024, Merxin Ltd., a UK-based company specializing in the design and supply of generic and customized inhaler devices, formed a partnership with OECHSLERhealth, a German manufacturer of medical devices. This collaboration led to the launch of the Soft Mist Inhalers (SMI) Powerhouse. This initiative aims to speed up market entry for drug developers and includes a partnership with OECHSLER Health to combine its manufacturing and assembly expertise with Merxin's proprietary SMI design. Together, they plan to set new industry standards in intellectual property protection, performance, reliability, speed, and cost-effectiveness.

In January 2024, Recipharm AB, a Sweden-based pharmaceutical company, joined forces with Medspray to expand the use of soft mist inhaler (SMI) technology beyond conventional respiratory treatments by developing soft mist nasal delivery devices for both single and combination drug products. This partnership aligns with Recipharm's strategy to innovate drug delivery solutions and diversify its offerings in advanced inhalation technologies. Medspray, based in the Netherlands, specializes in soft mist inhalers and spray delivery systems.

Major players in the soft mist inhalers market are Merck & Co., Novartis International AG, AstraZeneca plc, GlaxoSmithKline plc, Boehringer Ingelheim Pharma GmbH & Co. KG, Philips Respironics Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., 3M Healthcare, Omron Healthcare Inc., AptarGroup Inc., Chiesi Farmaceutici S.p.A., Cipla Limited, Hikma Pharmaceuticals plc, Mundipharma International Limited, Hovione Ltd., Vectura Group Limited, MannKind Corporation, H&T Presspart Ltd., Sunovion Pharmaceuticals Inc., Merxin Ltd., Adherium Limited.

North America was the largest region in the soft mist inhalers market in 2024. The regions covered in soft mist inhalers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the soft mist inhalers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The soft mist inhalers market consists of sales of respimat inhalers, tiotropium, and ipratropium. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Soft Mist Inhalers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on soft mist inhalers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for soft mist inhalers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The soft mist inhalers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Portable Soft Mist Inhalers; Stationary Soft Mist Inhalers
• 2) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Respiratory Diseases; Other Applications
• 3) By End-User: Hospitals And Clinics; Home Care Settings; Other End-Users
• Subsegments:
• 1) By Portable Soft Mist Inhalers: Handheld Reusable Soft Mist Inhalers; Disposable Single-Use Soft Mist Inhalers; Compact Travel-Friendly Inhalers; Pediatric-Use Portable Soft Mist Inhalers
• 2) By Stationary Soft Mist Inhalers: Homecare-Use Stationary Inhalers; Hospital-Grade Soft Mist Inhalers; Integrated Nebulizer Systems; Long-Term Therapy Devices
• Companies Mentioned: Merck & Co.; Novartis International AG; AstraZeneca plc; GlaxoSmithKline plc; Boehringer Ingelheim Pharma GmbH & Co. KG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Soft Mist Inhalers Market Characteristics

3. Soft Mist Inhalers Market Trends And Strategies

4. Soft Mist Inhalers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Soft Mist Inhalers Growth Analysis And Strategic Analysis Framework

• 5.1. Global Soft Mist Inhalers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Soft Mist Inhalers Market Growth Rate Analysis
• 5.4. Global Soft Mist Inhalers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Soft Mist Inhalers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Soft Mist Inhalers Total Addressable Market (TAM)

6. Soft Mist Inhalers Market Segmentation

• 6.1. Global Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Portable Soft Mist Inhalers
• Stationary Soft Mist Inhalers
• 6.2. Global Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Respiratory Diseases
• Other Applications
• 6.3. Global Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Home Care Settings
• Other End-Users
• 6.4. Global Soft Mist Inhalers Market, Sub-Segmentation Of Portable Soft Mist Inhalers, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Handheld Reusable Soft Mist Inhalers
• Disposable Single-Use Soft Mist Inhalers
• Compact Travel-Friendly Inhalers
• Pediatric-Use Portable Soft Mist Inhalers
• 6.5. Global Soft Mist Inhalers Market, Sub-Segmentation Of Stationary Soft Mist Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Homecare-Use Stationary Inhalers
• Hospital-Grade Soft Mist Inhalers
• Integrated Nebulizer Systems
• Long-Term Therapy Devices

7. Soft Mist Inhalers Market Regional And Country Analysis

• 7.1. Global Soft Mist Inhalers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Soft Mist Inhalers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Soft Mist Inhalers Market

• 8.1. Asia-Pacific Soft Mist Inhalers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Soft Mist Inhalers Market

• 9.1. China Soft Mist Inhalers Market Overview
• 9.2. China Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Soft Mist Inhalers Market

• 10.1. India Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Soft Mist Inhalers Market

• 11.1. Japan Soft Mist Inhalers Market Overview
• 11.2. Japan Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Soft Mist Inhalers Market

• 12.1. Australia Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Soft Mist Inhalers Market

• 13.1. Indonesia Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Soft Mist Inhalers Market

• 14.1. South Korea Soft Mist Inhalers Market Overview
• 14.2. South Korea Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Soft Mist Inhalers Market

• 15.1. Western Europe Soft Mist Inhalers Market Overview
• 15.2. Western Europe Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Soft Mist Inhalers Market

• 16.1. UK Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Soft Mist Inhalers Market

• 17.1. Germany Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Soft Mist Inhalers Market

• 18.1. France Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Soft Mist Inhalers Market

• 19.1. Italy Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Soft Mist Inhalers Market

• 20.1. Spain Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Soft Mist Inhalers Market

• 21.1. Eastern Europe Soft Mist Inhalers Market Overview
• 21.2. Eastern Europe Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Soft Mist Inhalers Market

• 22.1. Russia Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Soft Mist Inhalers Market

• 23.1. North America Soft Mist Inhalers Market Overview
• 23.2. North America Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Soft Mist Inhalers Market

• 24.1. USA Soft Mist Inhalers Market Overview
• 24.2. USA Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Soft Mist Inhalers Market

• 25.1. Canada Soft Mist Inhalers Market Overview
• 25.2. Canada Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Soft Mist Inhalers Market

• 26.1. South America Soft Mist Inhalers Market Overview
• 26.2. South America Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Soft Mist Inhalers Market

• 27.1. Brazil Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Soft Mist Inhalers Market

• 28.1. Middle East Soft Mist Inhalers Market Overview
• 28.2. Middle East Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Soft Mist Inhalers Market

• 29.1. Africa Soft Mist Inhalers Market Overview
• 29.2. Africa Soft Mist Inhalers Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Soft Mist Inhalers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Soft Mist Inhalers Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Soft Mist Inhalers Market Competitive Landscape And Company Profiles

• 30.1. Soft Mist Inhalers Market Competitive Landscape
• 30.2. Soft Mist Inhalers Market Company Profiles
  • 30.2.1. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim Pharma GmbH & Co. KG Overview, Products and Services, Strategy and Financial Analysis

31. Soft Mist Inhalers Market Other Major And Innovative Companies

• 31.1. Philips Respironics Inc.
• 31.2. Viatris Inc.
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Mylan N.V.
• 31.5. 3M Healthcare
• 31.6. Omron Healthcare Inc.
• 31.7. AptarGroup Inc.
• 31.8. Chiesi Farmaceutici S.p.A.
• 31.9. Cipla Limited
• 31.10. Hikma Pharmaceuticals plc
• 31.11. Mundipharma International Limited
• 31.12. Hovione Ltd.
• 31.13. Vectura Group Limited
• 31.14. MannKind Corporation
• 31.15. H&T Presspart Ltd.

32. Global Soft Mist Inhalers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Soft Mist Inhalers Market

34. Recent Developments In The Soft Mist Inhalers Market

35. Soft Mist Inhalers Market High Potential Countries, Segments and Strategies

• 35.1 Soft Mist Inhalers Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Soft Mist Inhalers Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Soft Mist Inhalers Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer